about
Somatic DNA mutation analysis in targeted therapy of solid tumoursAn Integrative Approach to Precision Cancer Medicine Using Patient-Derived XenograftsStructural variation discovery in the cancer genome using next generation sequencing: computational solutions and perspectivesAdvances in the Molecular Analysis of Soft Tissue Tumors and Clinical ImplicationsMulti-purpose utility of circulating plasma DNA testing in patients with advanced cancersPublic data and open source tools for multi-assay genomic investigation of diseaseThe Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityGenetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized MedicineHigh-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencingClinical analysis and interpretation of cancer genome dataGynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenesFirst do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer.p-Medicine: From data sharing and integration via VPH models to personalized medicine.Correlation of drug-induced apoptosis assay results with oncologist treatment decisions and patient response and survival.Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1.Mutations of epigenetic regulatory genes are common in thymic carcinomasIntegrated next-generation sequencing and avatar mouse models for personalized cancer treatment.Personalized medicine: new genomics, old lessonsSequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers.ClinSeK: a targeted variant characterization framework for clinical sequencing.Anticancer drug sensitivity prediction in cell lines from baseline gene expression through recursive feature selectionAn emerging toolkit for targeted cancer therapies.A Database of Gene-Environment Interactions Pertaining to Blood Lipid Traits, Cardiovascular Disease and Type 2 Diabetes.Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing Efficiency.Personalized tumor response assessment in the era of molecular medicine: cancer-specific and therapy-specific response criteria to complement pitfalls of RECISTOncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perilsTranslating genomic information into clinical medicine: lung cancer as a paradigm.Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare SettingsAbsence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumors.Mechanisms of chemoresistance in cancer stem cells.Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies.New targetable oncogenes in non-small-cell lung cancer.Comparison and validation of genomic predictors for anticancer drug sensitivity.Management of incidental findings in clinical genomic sequencingBlood-brain barrier remodeling during brain metastasis formation.Existing and emerging technologies for tumor genomic profilingAdvancing precision medicine for prostate cancer through genomics.Recent progress and clinical importance on pharmacogenetics in cancer therapy.
P2860
Q26770324-88A9BF5F-425B-42FE-940F-E0179F34BE6DQ26772895-C3D5C381-1AD4-4FE7-B5C0-CA8BEB272AAEQ26991436-A2C75394-9081-43F5-8E5C-CD01B8C875A3Q27021848-4F207720-FD42-4805-AA06-FBB10A755E7AQ28484970-355B7029-F2D6-4E73-B400-504D55C9FD9FQ28596241-476AA50C-B71E-45E8-B91B-799BC802EE70Q29547693-7CE909CB-93AA-40E0-B242-43D551240879Q30513982-A71F58B7-2F02-4B9C-B9D1-0A5875D4B88FQ30514084-EBACF324-C567-42EB-87BA-C5FE7FABBDA7Q30617093-266CB072-E2B6-42B2-8862-9264F902A9DFQ33837836-88F31957-7AE9-4C08-8DB9-D4DCC9A6EC11Q34050186-30E76278-E515-4CC3-ABCC-0DEEFA4C38DAQ34104204-30E2F4DB-EDED-48CB-8CC7-9BE8D722EBE9Q34140068-9665EBA6-4364-4EDD-A379-6C0E04FF3F36Q34256053-2FA1B43E-AB72-475F-9A25-EDDD53426CD2Q34464009-8C173B65-AFA6-4EA0-A506-94266B20851AQ34648225-5086DDE4-6532-48A1-A492-1BE94D8DAC75Q35067532-4E66051A-501C-42E6-891C-35B802ABCBB4Q35082635-71C60FED-CB95-4B59-AB6F-9471A9E505EEQ35178113-5F7B4613-1C64-42E5-93F9-DBEE0F02FF91Q35453542-13D38BF2-2E16-4C15-8F1C-4264E9126468Q35540606-722673EB-E669-4CA4-B3DA-A0DA330CCDE5Q35677556-B6C2CABB-9C84-4C1E-B255-5E5D4FA1513CQ35694357-56415B2A-3945-4CCD-ADD6-B184359624F0Q35745829-8C4F0EF9-1B16-4B48-89AD-E9D70E0892DEQ35852269-D1B544FC-F2E1-4E83-9349-2CF841C0010FQ36015295-E4240180-004B-47D6-8F13-3A548667339CQ36038823-9A49DAE9-BB3B-4805-9813-2EDAD1E21238Q36354845-CBE8451E-2D32-4EEE-BB28-286567DAECD8Q36367741-D0180408-0EEE-4842-BAD6-9D806077FC54Q36511670-0A1AF644-FA9A-4FAC-A2A3-6EAE346ED61BQ36591484-A0591C63-4D36-4EAB-B149-2168E8E6FF81Q36660664-1A4C0AE4-77E6-41A4-B412-8CF2D0AB4E94Q36660677-AF5C568E-E1F1-4CFE-9215-21184770DA27Q37039879-24A7AA04-50BB-4FEB-A58A-139DE858CE6FQ37148891-14877475-CB6B-4AC5-A8D1-28D6DEC6F3F1Q37217055-7251FB47-A7D4-4E2A-8036-7A1610FEF1A1Q37255147-61B2F908-A729-4E02-978A-B1AC28E5DB41Q37255151-CBF0D9A4-F3C5-4AC6-A71B-D9CB6D3A3470Q37382559-9F94E224-7494-420A-9955-DF376CD34E94
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical implications of the cancer genome
@ast
Clinical implications of the cancer genome
@en
Clinical implications of the cancer genome
@nl
type
label
Clinical implications of the cancer genome
@ast
Clinical implications of the cancer genome
@en
Clinical implications of the cancer genome
@nl
prefLabel
Clinical implications of the cancer genome
@ast
Clinical implications of the cancer genome
@en
Clinical implications of the cancer genome
@nl
P2860
P356
P1476
Clinical implications of the cancer genome
@en
P2093
Laura E Macconaill
P2860
P304
P356
10.1200/JCO.2009.27.4944
P407
P577
2010-10-25T00:00:00Z